Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 10:48 PM
NCT ID:
NCT01578967
Group ID:
EG000
Title:
ABVD Followed by Brentuximab Vedotin
Description:
Single arm trial
Brentuximab vedotin: IV, 1.8mg/kg, every 3 weeks for 6 cycles.
ABVD: Doxorubicin - 25mg/m2 IV over 3-5 minutes, Day 1 and 15, every 28 days, 2-6 cycles.
Bleomycin - 10u/m2 IV, Day 1 and 15, every 28 days, 2-6 cycles Vinblastine - 6mg/m2 IV over 3-5 minutes, Day 1 and 15, every 28 days, 2-6 cycles.
Dacarbazine - 375mg/m2 IV over 30 minutes, Day 1 and 15, every 28 days, 2-6 cycles.
Deaths Number Affected:
1
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
41
Other Number Affected:
41
Other Number At Risk:
41
Study:
NCT01578967
Results Section:
NCT01578967
Adverse Events Module:
NCT01578967